Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: Comparison with risperidone

Behavioural Brain Research

Volumn 167, Issue 1, 2006, Pages 118-127

  Andreasen, J T ^a   Andersen, K K ^b   Nielsen, E O ^a   Mathiasen, L ^a   Mirza, N R ^a  

^a NEUROSEARCH A S   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Bungaratoxin; Clozapine; Mouse; Nicotine; PCP; PPI; Risperidone; Strain

Indexed keywords

CLOZAPINE; EPIBATIDINE; IODINE 125; NICOTINE; NICOTINIC RECEPTOR; PHENCYCLIDINE; RISPERIDONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EVOKED AUDITORY RESPONSE; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HALLUCINOGENS; MICE; MICE, INBRED BALB C; NEURAL INHIBITION; NICOTINE; NICOTINIC AGONISTS; PHENCYCLIDINE; RISPERIDONE; SPECIES SPECIFICITY; STARTLE REACTION;

EID: 30344436976     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.08.023     Document Type: Article

References (55)

1. J.B. Acri Nicotine modulates effects of stress on acoustic startle reflexes in rats: dependence on dose, stressor and initial reactivity Psychopharmacology (Berl) 116 1994 255 265
2. J.B. Acri, K.J. Brown, M.I. Saah, and N.E. Grunberg Strain and age differences in acoustic startle responses and effects of nicotine in rats Pharmacol Biochem Behav 50 1995 191 198
3. 3H] methylcarbamylcholine in rat brain Eur J Pharmacol 253 1994 261 267
4. 3 receptors mediate inhibition of acetylcholine release in cortical tissue Nature 338 1989 762 763
5. D. Braff, C. Stone, E. Callaway, M. Geyer, I. Glick, and L. Bali Prestimulus effects on human startle reflex in normals and schizophrenics Psychophysiology 15 1978 339 343
6. D.L. Braff, N.R. Swerdlow, and M.A. Geyer Symptom correlates of prepulse inhibition deficits in male schizophrenic patients Am J Psychiatry 156 1999 596 602
7. C.A. Briggs, D.J. Anderson, J.D. Brioni, J.J. Buccafusco, M.J. Buckley, and J.E. Campbell Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo Pharmacol Biochem Behav 57 1997 231 241
8. A.E. Bullock, B.S. Slobe, V. Vazquez, and A.C. Collins Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response Behav Neurosci 111 1997 1353 1360
9. A.C. Collins, L.L. Miner, and M.J. Marks Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse Pharmacol Biochem Behav 30 1988 269 278
10. J.N. Crawley, J.K. Belknap, A. Collins, J.C. Crabbe, W. Frankel, and N. Henderson Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies Psychopharmacology (Berl) 132 1997 107 124
11. 3H]acethylcholine release in rat cortical synaptosomes Pharmacol Res 35 1997 351 354
12. M.W. Decker, A.W. Bannon, P. Curzon, K.L. Gunther, J.D. Brioni, and M.W. Holladay ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys J Pharmacol Exp Ther 283 1997 247 258
13. C.V. Della, I. Hofer, I. Weiner, and J. Feldon The effects of smoking on acoustic prepulse inhibition in healthy men and women Psychopharmacology (Berl) 137 1998 362 368
14. E. Duncan, S. Madonick, S. Chakravorty, A. Parwani, S. Szilagyi, and T. Efferen Effects of smoking on acoustic startle and prepulse inhibition in humans Psychopharmacology (Berl) 156 2001 266 272
15. M.M. Faraday, V.A. O'Donoghue, and N.E. Grunberg Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex Pharmacol Biochem Behav 62 1999 273 284
16. M.M. Faraday, M.A. Rahman, P.M. Scheufele, and N.E. Grunberg Nicotine administration impairs sensory gating in Long-Evans rats Pharmacol Biochem Behav 61 1998 281 289
17. M.A. Geyer, and D.L. Braff Startle habituation and sensorimotor gating in schizophrenia and related animal models Schizophr Bull 13 1987 643 668
18. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology (Berl) 156 2001 117 154
19. M. Gopalakrishnan, B. Buisson, E. Touma, T. Giordano, J.E. Campbell, and I.C. Hu Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor Eur J Pharmacol 290 1995 237 246
20. T.J. Gould, M. Rukstalis, and M.C. Lewis Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice Neurosci Lett 377 2005 85 90
21. F.K. Graham Presidential Address, 1974. The more or less startling effects of weak prestimulation Psychophysiology 12 1975 238 248
22. H.S. Hoffman, and J.L. Searle Acoustic and temporal factors in the evocation of startle J Acoust Soc Am 43 1968 269 282
23. J.R. Hughes, D.K. Hatsukami, J.E. Mitchell, and L.A. Dahlgren Prevalence of smoking among psychiatric outpatients Am J Psychiatry 143 1986 993 997
24. W.R. Kem The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21) Behav Brain Res 113 2000 169 181
25. V. Kumari, S.A. Checkley, and J.A. Gray Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers Psychopharmacology (Berl) 128 1996 54 60
26. V. Kumari, P.A. Cotter, S.A. Checkley, and J.A. Gray Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers Psychopharmacology (Berl) 132 1997 389 395
27. V. Kumari, W. Soni, and T. Sharma Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia Hum Psychopharmacol 16 2001 321 326
28. E.D. Levin, C. Bettegowda, J. Blosser, and J. Gordon AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats Behav Pharmacol 10 1999 675 680
29. E.D. Levin, W. Wilson, J.E. Rose, and J. McEvoy Nicotine-haloperidol interactions and cognitive performance in schizophrenics Neuropsychopharmacology 15 1996 429 436
30. 3H]epibatidine Eur J Pharmacol 278 1995 R1 R2
31. E.R. Lyon A review of the effects of nicotine on schizophrenia and antipsychotic medications Psychiatr Serv 50 1999 1346 1350
32. T. Mackeprang, K.T. Kristiansen, and B.Y. Glenthoj Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients Biol Psychiatry 52 2002 863 873
33. M.J. Marks, E. Romm, S.M. Campbell, and A.C. Collins Variation of nicotinic binding sites among inbred strains Pharmacol Biochem Behav 33 1989 679 689
34. N.R. Mirza, A. Misra, and J.L. Bright Different outcomes after acute and chronic treatment with nicotine in pre-pulse inhibition in Lister hooded rats Eur J Pharmacol 407 2000 73 81
35. G. Mullen, J. Napier, M. Balestra, T. DeCory, G. Hale, and J. Macor (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor J Med Chem 43 2000 4045 4050
36. S.V. Nayak, P. Ronde, A.D. Spier, S.C. Lummis, and R.A. Nichols Calcium changes induced by presynaptic 5-hydroxytryptamine-3 serotonin receptors on isolated terminals from various regions of the rat brain Neuroscience 91 1999 107 117
37. B. Olivier, C. Leahy, T. Mullen, R. Paylor, V.E. Groppi, and Z. Sarnyai The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology (Berl) 156 2001 284 290
38. B. Oranje, C.J. Van Oel, C.C. Gispen-De Wied, M.N. Verbaten, and R.S. Kahn Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia J Clin Psychopharmacol 22 2002 359 365
39. R.L. Papke, E. Meyer, T. Nutter, and V.V. Uteshev Alpha7 receptor-selective agonists and modes of alpha7 receptor activation Eur J Pharmacol 393 2000 179 195
40. R.L. Papke, and J.S. Thinschmidt The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes Neurosci Lett 256 1998 163 166
41. R. Paylor, and J.N. Crawley Inbred strain differences in prepulse inhibition of the mouse startle response Psychopharmacology (Berl) 132 1997 169 180
42. W. Perry, M.A. Geyer, and D.L. Braff Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients Arch Gen Psychiatry 56 1999 277 281
43. G. Rammes, B. Eisensamer, U. Ferrari, M. Shapa, G. Gimpl, and K. Gilling Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner Mol Psychiatry 9 2004 846 858 818
44. B.V. Sastry, M.B. Chance, G. Singh, J.L. Horn, and V.E. Janson Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time Pharmacology 50 1995 128 136
45. R. Schreiber, M. Dalmus, and V.J. De Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice Psychopharmacology (Berl) 159 2002 248 257
46. J.K. Simosky, K.E. Stevens, L.E. Adler, and R. Freedman Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism Psychopharmacology (Berl) 165 2003 386 396
47. R.C. Smith, A. Singh, M. Infante, A. Khandat, and A. Kloos Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia Neuropsychopharmacology 27 2002 479 497
48. C. Spielewoy, and A. Markou Strain-specificity in nicotine attenuation of phencyclidine-induced disruption of prepulse inhibition in mice: relevance to smoking in schizophrenia patients Behav Genet 34 2004 343 354
49. K.E. Stevens, R. Freedman, A.C. Collins, M. Hall, S. Leonard, and M.J. Marks Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains Neuropsychopharmacology 15 1996 152 162
50. K.E. Stevens, W.R. Kem, V.M. Mahnir, and R. Freedman Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice Psychopharmacology (Berl) 136 1998 320 327
51. N.R. Swerdlow, and M.A. Geyer Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia Schizophr Bull 24 1998 285 301
52. N.L. Vadlamani, R.B. Pontani, and A.L. Misra Effect of chronic nicotine pre-treatment on phencyclidine (PCP) disposition in the rat Arch Int Pharmacodyn Ther 265 1983 4 12
53. K.M. Van, K. Selbach, R. Schneider, E. Schiegel, F. Boess, and R. Schreiber AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors Psychopharmacology (Berl) 172 2004 375 383
54. D.S. Woodruff-Pak, Y.T. Li, and W.R. Kem A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain Brain Res 645 1994 309 317
55. D.M. Ziedonis, and T.P. George Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues Schizophr Bull 23 1997 247 254